Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Holmium Laser Enucleation of the Prostate Versus Bipolar Transurethral Enucleation of the Prostate in Management of Benign Prostatic Hyperplasia A Randomized Controlled Trial

NCT04275076 is registered in ClinicalTrials.gov with Ahmed Maher Gamil Ahmed Higazy as lead sponsor.

NCT NCT04275076
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04275076 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Holmium Laser Enucleation of the Prostate Versus Bipolar Transurethral Enucleation of the Prostate in Management of Benign Prostatic Hyperplasia A Randomized Controlled Trial
Lead sponsor
Ahmed Maher Gamil Ahmed Higazy
Phase
Phase 3
Overall status
Completed
Start date
February 1, 2018
Completion date
February 1, 2020
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate hyperplasia